This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Cannabis Global, Inc., is implementing a program to produce commercially viable quantities of tetrahydrocannabivarin (THC-V) for use in its own products to be released later this month.
MCTC Holdings, Inc. has undertaken Project Varin, a program to develop new delivery systems for tetrahydrocannabivarin (THC-V), a rare cannabinoid found in Cannabis sativa purported to suppress appetite.
